Signaling mechanisms inducing hyporesponsiveness of phagocytes during systemic inflammation

Abstract

The inflammatory responsiveness of phagocytes to exogenous and endogenous stimuli is tightly regulated. This regulation plays an important role in systemic inflammatory response syndromes (SIRSs). In SIRSs, phagocytes initially develop a hyperinflammatory response, followed by a secondary state of hyporesponsiveness, a so-called “tolerance.” This hyporesponsiveness can be induced by endotoxin stimulation of Toll-like receptor 4 (TLR4), resulting in an ameliorated response after subsequent restimulation. This modification of inflammatory response patterns has been described as innate immune memory. Interestingly, tolerance can also be triggered by endogenous TLR4 ligands, such as the alarmins myeloid-related protein 8 (MRP8, S100A8) and MRP14 (S100A9), under sterile conditions. However, signaling pathways that trigger hyporesponsiveness of phagocytes in clinically relevant diseases are only barely understood. Through our work, we have now identified 2 main signaling cascades that are activated during MRP-induced tolerance of phagocytes. We demonstrate that the phosphatidylinositol 3-kinase/AKT/GSK-3β pathway interferes with NF-κB–driven gene expression and that inhibition of GSK-3β mimics tolerance in vivo. Moreover, we identified interleukin-10–triggered activation of transcription factors STAT3 and BCL-3 as master regulators of MRP-induced tolerance. Accordingly, patients with dominant-negative STAT3 mutations show no tolerance development. In a clinically relevant condition of systemic sterile stress, cardiopulmonary bypass surgery, we confirmed the initial induction of MRP expression and the tolerance induction of monocytes associated with nuclear translocation of STAT3 and BCL-3 as relevant mechanisms. Our data indicate that the use of pharmacological JAK-STAT inhibitors may be promising targets for future therapeutic approaches to prevent complications associated with secondary hyporesponsiveness during SIRS.

Phagocytosis–Inflammation Crosstalk in Sepsis: New Avenues for Therapeutic Intervention

“…During these processes, several damage-associated molecular patterns (DAMPs) (such as S100A8 and S100A9) are released into the bloodstream. These DAMPs act as endogenous TLR4 ligands and are able to induce a state of “tolerance” in monocytes, similar to that observed after LPS challenge ( 82 ). Moreover, SIRS can induce profound changes in gastro-intersticial (GI) permeability ( 83 , 84 ), which leads to the translocation of symbiotic bacteria from the GI tract to the blood stream, finally resulting in multiple amplification of inflammatory responses and switching “sterile” SIRS into “nonsterile” with bacterial (PAMPs) immune-stimulation.…”

RIP3 deficiency alleviates liver fibrosis by inhibiting ROCK1–TLR4–NF‐κB pathway in macrophages

“…Currently, 2 isoforms of ROCKs have been identified: ROCK1 and ROCK2 (28). The 2 molecules are the major mediators of RhoA-induced stress and focal adhesion formation (29). As the direct downstream effector of RhoA, ROCK1 could enhance cell proliferation and promote epithelial differentiation keratocytes.…”

IL6 inhibition of inflammatory S100A8/9 proteins is NF‐κB mediated in essential thrombocythemia

“…S100A8/9 induced NF‐κB activity and the production of TNF‐α, IL6, and IL8, but not IL10, in purified blood monocytes . However, S100A8 induction by Escherichia coli DNA required IL10 signalling, while S100A8 participated in stimulation of IL10 secretion by human monocytes . Overexpression of S100A8 and S00A9 in macrophages led to enhanced IL10 gene expression .…”